The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
BBIO · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | KEQU | GEHC | MIR | BBIO |
|---|---|---|---|---|
| Moat Score (0–100) | 49 | 50 (highest) | 50 (highest) | 49 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 70 | 54 | 80 (highest) | 55 |
| Pricing power | 9 | 70 | 71 | 91 (highest) |
| Returns on capital | 48 | 63 (highest) | 0 | — |
| Balance-sheet safety | 55 (highest) | 41 | 53 | 28 |
| Capital allocation | 66 (highest) | 21 | 44 | 24 |
| 22% below value if growth stopped today | No price data | No price data | No price data | |
| Market cap | $103M | Not reported | Not reported | $16.4B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2026 | FY2025 | FY2025 | FY2025 |